Testing effectiveness (Phase 2)Looking for participantsNCT03026140
What this trial is testing
Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
Who this might be right for
Colon Carcinoma
The Netherlands Cancer Institute 353